Kelman Lazarov, Inc. Merck & Co., Inc. Transaction History

Kelman Lazarov, Inc.

$507 Million
Q4 2024

A detailed history of Kelman Lazarov, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Kelman Lazarov, Inc. holds 2,142 shares of MRK stock, worth $191,709. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,142

Previous 2,054 4.28%

Holding current value

$191,709

Previous $233,000 8.58%

% of portfolio

0.04%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$96.31 - $114.76 $8,475 - $10,098	88 Added 4.28%	2,142 $213,000
Q2 2024 Aug 12, 2024	SELL	$123.8 - $132.96 $54,719 - $58,768	-442 Reduced 17.71%	2,054 $254,000
Q1 2024 May 09, 2024	BUY	$113.24 - $131.95 $452 - $527	4 Added 0.16%	2,496 $329,000
Q4 2023 Feb 01, 2024	SELL	$100.18 - $109.02 $3,406 - $3,706	-34 Reduced 1.35%	2,492 $271,000
Q3 2023 Oct 30, 2023	BUY	$102.95 - $114.33 $7,103 - $7,888	69 Added 2.81%	2,526 $260,000
Q2 2023 Aug 04, 2023	BUY	$108.61 - $118.38 $9,231 - $10,062	85 Added 3.58%	2,457 $283,000
Q1 2023 May 04, 2023	BUY	$102.94 - $114.86 $48,999 - $54,673	476 Added 25.11%	2,372 $252,000
Q4 2022 Feb 06, 2023	BUY	$87.44 - $112.11 $165,786 - $212,560	1,896 New	1,896 $210,000
Q2 2020 Jul 29, 2020	SELL	$70.42 - $80.13 $215,203 - $244,877	-3,056 Closed	0 $0
Q1 2020 Apr 27, 2020	SELL	$63.36 - $87.82 $52,335 - $72,539	-826 Reduced 21.28%	3,056 $235,000
Q4 2019 Jan 29, 2020	SELL	$77.58 - $87.54 $244,454 - $275,838	-3,151 Reduced 44.8%	3,882 $353,000
Q2 2019 Jul 22, 2019	SELL	$69.84 - $81.59 $6,215 - $7,261	-89 Reduced 1.25%	7,033 $590,000
Q1 2019 May 08, 2019	BUY	$69.58 - $79.36 $49,193 - $56,107	707 Added 11.02%	7,122 $592,000
Q4 2018 Feb 11, 2019	SELL	$65.24 - $75.71 $15,005 - $17,413	-230 Reduced 3.46%	6,415 $490,000
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $5,019 - $5,902	-87 Reduced 1.29%	6,645 $471,000
Q2 2018 Aug 03, 2018	BUY	$50.83 - $59.72 $965 - $1,134	19 Added 0.28%	6,732 $409,000
Q4 2017 Jan 23, 2018	SELL	$51.62 - $61.64 $4,439 - $5,301	-86 Reduced 1.26%	6,713 $378,000
Q3 2017 Oct 05, 2017	BUY	$58.67 - $63.13 $398,897 - $429,220	6,799	6,799 $435,000

Others Institutions Holding MRK

# of Institutions

3,952

Shares Held

1.94B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $227B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelman Lazarov, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kelman Lazarov, Inc. with notifications on news.

Account

Kelman Lazarov, Inc. Merck & Co., Inc. Transaction History